Skip to main content
Mednow Inc. logo

Mednow Inc. — Investor Relations & Filings

Ticker · MNOW ISIN · CA58503L2021 TSXV Wholesale and retail trade
Open in API
Filings indexed 132 across all filing types
Latest filing 2022-02-24 Capital/Financing Update
Country CA Canada
Listing TSXV MNOW

About Mednow Inc.

https://mednow.ca/

Mednow Inc. is a full-service virtual pharmacy utilizing a digital-first approach to deliver prescription medications, over-the-counter products, and comprehensive health services. The company provides fast, free delivery of medications and health products. Core offerings include unlimited virtual consultations with certified pharmacists, prescription management tools accessible via web or mobile application, and direct billing to insurance providers. A key service is PillSmart®, which organizes multiple daily medications into convenient, single-dose packages at no additional cost. Mednow focuses on improving patient access and adherence by offering expert advice and medication reviews seven days a week.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a corporate update press release from Mednow Inc. providing financial forecasts for calendar years 2022 and 2023, operational milestones, partnership announcements, and other business updates. It includes forward-looking statements and financial outlook information but does not contain actual financial statements or detailed financial analysis. The document is not a full annual or interim report, nor is it an earnings release with key financial highlights only. It is also not a regulatory filing or certification. The content focuses on business progress and future expectations rather than reporting past financial results. Therefore, it fits best into the category of Capital/Financing Update (CAP), as it provides updates on financial forecasts and corporate progress relevant to investors and stakeholders.
2022-02-24 English
NI 44-101 Notice of intent to qualify – English.pdf
Capital/Financing Update Classification · 95% confidence The document is a short notice declaring the intention of Mednow Inc. to be qualified under National Instrument 44-101 for short form prospectus distributions. It is addressed to various securities commissions and signed by the CEO. The document does not contain financial data, detailed financing updates, or actual prospectus filings, but rather a regulatory notice of intent related to capital raising. This fits best under Capital/Financing Update (CAP) as it relates to the company's financing activities and regulatory qualification for a prospectus.
2022-02-15 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a certification filed by the Chief Financial Officer related to the annual filings of the issuer, specifically referencing the AIF (Annual Information Form), annual financial statements, and annual MD&A for the financial year ended July 31, 2021. The document is a certification under Form 52-109F1, which is a regulatory attestation of the accuracy and completeness of the annual filings. It does not contain the actual financial statements or substantive financial data but rather certifies the filings. The document length is 3217 characters, which is relatively short and consistent with a certification letter rather than a full report. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual annual report or AIF. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-02-15 English
Other.pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of Mednow Inc. regarding the accuracy and fair presentation of the annual filings, including the AIF, annual financial statements, and annual MD&A for the financial year ended July 31, 2021. It is a Form 52-109F1 certificate, which is a regulatory attestation related to annual filings. The document does not contain actual financial data or the full annual report but is a certification letter. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS), not as the report itself (like 10-K or AIF). The document length is short (3199 characters), and it is clearly a certification, not the full report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2022-02-15 English
Annual information form - English.pdf
Regulatory Filings Classification · 90% confidence The document is titled 'Annual Information Form' (AIF) for Mednow Inc. for the year ended July 31, 2021, dated February 11, 2022. It contains detailed sections such as corporate structure, business description, risk factors, dividends, capital structure, directors and officers, legal proceedings, audit committee, and other comprehensive corporate and financial information. The AIF is a regulatory filing commonly used in Canadian securities regulation to provide detailed annual information about a company, including business overview, risk factors, and governance, but it is distinct from the Annual Report (10-K) which focuses more on financial statements and performance. Given the detailed nature and length (15,000 characters), and the presence of extensive business and risk disclosures, this document fits the category of an Annual Information Form, which is a type of regulatory filing but more specific than a generic regulatory filing. However, since the provided classification list does not explicitly include 'Annual Information Form' as a separate category, and the document is not a full Annual Report (10-K) or Audit Report (AR), the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. Confidence is high due to the clear identification of the document as an Annual Information Form and its detailed content.
2022-02-15 English
Other.PDF
M&A Activity Classification · 100% confidence The document is titled 'SHARE PURCHASE AGREEMENT' and contains detailed sections typical of a legal contract for the sale and purchase of shares between parties. It includes definitions, representations, warranties, purchase price, conditions precedent, indemnity, exclusivity, termination, and general provisions. There is no indication that this is a financial report, earnings release, regulatory filing, or any other type of corporate disclosure report. Instead, it is a legal agreement related to a transaction involving shares, which fits the category of M&A Activity filings. The document length is substantial (15,000 characters), indicating it is the full agreement rather than a brief announcement. Therefore, the appropriate classification is M&A Activity (TAR).
2022-02-15 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.